Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.34 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31607268 | 1.00 | CYP1A2 (0.38) | CYP1A2ACHEBACE1SIRT2GPR84 | |
| SCHEMBL31607267 | 1.00 | CYP1A2 (0.38) | CYP1A2ACHEBACE1SIRT2GPR84 | |
| SCHEMBL30886701 | 0.98 | CYP1A2 (0.35) | CYP1A2ACHEBACE1SIRT2GPR84 | |
| SCHEMBL664979 | 0.84 | ELANE (0.37) | CYP1A2ACHEBACE1GPR84ELANE | |
| SCHEMBL4951065 | 0.77 | — | — | |
| SCHEMBL5105798 | 0.76 | CTRC (0.33) | CYP1A2MAPTTHRB | |
| SCHEMBL6711983 | 0.75 | — | — | |
| SCHEMBL4867436 | 0.72 | ACHE (0.43) | ACHEBACE1GPR84ALOX5 | |
| Water SCHEMBL8997397 | 0.70 | PTGS2 (0.33) | ACHETHRATHRB | |
| SCHEMBL6545218 | 0.69 | NPC1 (0.33) | CYP1A2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120091758-A | Arthropod control composition | 弗门尼舍有限公司 | 2025-06-03 | — | — | CN | disclosed |